We are live on ! Find out more
Aspiriant LLC

Aspiriant LLC Portfolio holdings

AUM $4.08B Turnover 21.3%
1-Year Est. Return 12.02%
 

Aspiriant is an employee-owned wealth management firm with accounting roots that pairs financial planning with tax-conscious investing. Formed in 2008 and briefly named Kochis Fitz/Quintile that year, it has since brought together several firms whose client relationships go back many years, in some cases decades. Its investment approach is globally diversified and value-oriented. The firm advises the Aspiriant Affiliated Mutual Funds, which give clients access to private investments. Its clients are mainly high net worth individuals and families, along with professional fiduciaries.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+12.02%
3 Year Est. Return
+52.7%
5 Year Est. Return
+47.97%
10 Year Est. Return
+142.06%
AUM
$4.08B
AUM Growth
+$32.7M
Cap. Flow
+$42.9M
Cap. Flow %
1.05%
Top 10 Hldgs %
64.79%
Holding
460
New
60
Increased
185
Reduced
136
Closed
38
Avg Time Held
4.2 years
Top 10 Avg Time Held
6 years
Top 20 Avg Time Held
6.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.16%
2 Technology 4.02%
3 Financials 1.91%
4 Communication Services 1.2%
5 Healthcare 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MGK icon
201
Vanguard Morningstar Mega Cap Growth ETF
MGK
$29B
$771K 0.02%
8,323
-3,877
-32% -$346K
2024 Q1
10 quarters
RDIV icon
202
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.46B
$768K 0.02%
13,430
– –
2025 Q3
4 quarters
PM icon
203
Philip Morris
PM
$291B
$754K 0.02%
3,951
-278
-7% -$52.5K
2025 Q1
6 quarters
CP icon
204
Canadian Pacific Kansas City
CP
$79.5B
$754K 0.02%
8,857
– –
2023 Q2
13 quarters
RYTM icon
205
Rhythm Pharmaceuticals
RYTM
$8.1B
$751K 0.02%
7,888
-20,072
-72% -$2.14M
2026 Q1
2 quarters
NOBL icon
206
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$751K 0.02%
13,880
+5,776
+71% +$330K
2022 Q2
17 quarters
PAYX icon
207
Paychex
PAYX
$39.7B
$734K 0.02%
7,454
-4,985
-40% -$577K
2019 Q3
28 quarters
LMT icon
208
Lockheed Martin
LMT
$132B
$732K 0.02%
1,437
-16
-1% -$8.8K
2022 Q4
15 quarters
MS icon
209
Morgan Stanley
MS
$274B
$728K 0.02%
3,870
-30
-0.8% -$6.37K
2022 Q1
18 quarters
SPG icon
210
Simon Property Group
SPG
$72.6B
$725K 0.02%
3,613
+16
+0.4% +$3.48K
2024 Q1
10 quarters
SPLV icon
211
Invesco S&P 500 Low Volatility ETF
SPLV
$7.4B
$722K 0.02%
10,244
– –
2021 Q2
21 quarters
HYG icon
212
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18B
$707K 0.02%
9,155
+2,698
+42% +$214K
2024 Q2
9 quarters
IWO icon
213
iShares Russell 2000 Growth ETF
IWO
$12.7B
$682K 0.02%
1,911
-1,004
-34% -$379K
2018 Q2
33 quarters
SPYM icon
214
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$681K 0.02%
7,592
+15
+0.2% +$1.34K
2025 Q1
6 quarters
A icon
215
Agilent Technologies
A
$49.4B
$652K 0.02%
3,786
+73
+2% +$10.7K
2026 Q1
2 quarters
SCHA icon
216
Schwab U.S Small- Cap ETF
SCHA
$20.4B
$626K 0.02%
19,177
+1,636
+9% +$56K
2025 Q3
4 quarters
STX icon
217
Seagate
STX
$120B
$624K 0.02%
677
+78
+13% +$66.6K
2026 Q2
1 quarter
LSF icon
218
Laird Superfood
LSF
$24.3M
$612K 0.02%
175,958
+84,508
+92% +$348K
2026 Q2
1 quarter
BBHL icon
219
BBH Select Large Cap ETF
BBHL
$514M
$609K 0.01%
35,333
– –
2025 Q4
3 quarters
GS icon
220
Goldman Sachs
GS
$244B
$609K 0.01%
676
-538
-44% -$550K
2021 Q1
22 quarters
IUSB icon
221
iShares Core Universal USD Bond ETF
IUSB
$50.5B
$609K 0.01%
13,803
-17,725
-56% -$803K
2023 Q4
11 quarters
URTH icon
222
iShares MSCI World ETF
URTH
$9.13B
$600K 0.01%
2,911
+1,735
+148% +$358K
2025 Q4
3 quarters
FIX icon
223
Comfort Systems
FIX
$39B
$599K 0.01%
362
-7
-2% -$11.8K
2026 Q2
1 quarter
VGUS icon
224
Vanguard Ultra-Short Treasury ETF
VGUS
$1.08B
$597K 0.01%
+7,898
New +$597K
2026 Q3
0 quarters
LIN icon
225
Linde
LIN
$234B
$582K 0.01%
1,226
+248
+25% +$122K
2021 Q4
19 quarters

Similar funds

Aspiriant LLC's Q3 2026 Portfolio in Review

As of Q3 2026, Aspiriant LLC held 460 positions worth $4.08B, up 0.81% from $4.05B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Aspiriant LLC's Q3 2026 filing shows 60 new, 185 increased, 136 reduced and 38 closed positions. Its largest new stake was iShares California Muni Bond ETF: 47,237 shares worth $2.56M. The largest sale was Dimensional US Core Equity 2 ETF, an estimated $14.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Financials.

  • Aspiriant LLC's largest Q3 2026 buy was iShares California Muni Bond ETF: 47,237 shares worth $2.56M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q3 2026, an estimated $19.6M increase.
  • Aspiriant LLC's biggest Q3 2026 reduction was Vanguard S&P Small-Cap 600 Value ETF, cutting an estimated $2.25M.
  • Aspiriant LLC fully exited Dimensional US Core Equity 2 ETF in Q3 2026, selling an estimated $14.2M.
  • Aspiriant LLC's ten largest holdings make up 65% of its $4.08B portfolio in Q3 2026.
  • Aspiriant LLC opened 60 new positions and closed 38 in Q3 2026.
  • Aspiriant LLC's portfolio value rose 0.81% quarter-over-quarter to $4.08B.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.